Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Head and Neck Adenoid Cystic Carcinoma

NCT00581360 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00581360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00581360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Head and Neck Adenoid Cystic Carcinoma
Lead sponsor
University of Pittsburgh
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
June 30, 2011
Enrollment
10 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

adenoid cystic carcinoma